WebBrightGene Bio-Medical Technology Co Ltd (BrightGene) is a biopharmaceutical company that manufacturing, research and develop of generic drugs. The company’s pipeline … WebNov 8, 2024 · Investors of BrightGene Bio-Medical Technology include Sequoia Capital China, GF Qianhe, HighLight Capital, Rongda Microloan, Tririver Capital and 9 more. Discover the right solution for your team The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help …
The Culture Media of Microbiology market size is ... - MarketWatch
WebJan 7, 2024 · BrightGene has raised a total of CN¥550M in funding over 1 round. This was a Venture - Series Unknown round raised on Jan 7, 2024. BrightGene is registered under the ticker SSE:688166 . Their stock opened with CN¥12.71 in its Nov 8, 2024 IPO. BrightGene is funded by 4 investors. WebBrightGene Bio-Medical Technology Co., Ltd. is a public listed China-based company mainly engaged in chemical pharmaceutical business. The company is a research driven biopharmaceutical company that engages in the R&D and manufacturing of innovative medicine as wel l as special generic APIs and FDFs with high-tech barriers having a … herbarium p
BrightGene Fine Chemical Co Ltd WHO - Prequalification of …
WebCompany profile for BrightGene Bio-Medical Technology Co. Ltd. A including key executives, insider trading, ownership, revenue and average growth rates. View detailed … WebMar 2, 2024 · The Shanghai Stock Exchange said in an statement Sunday that BrightGene Bio-Medical Technology has not gained approval from China’s drug regulator to make … WebBrightGene Fine Chemical Co Ltd, No.22 Binjiang South Road,, Taixing Economic Development Zone, Taizhou, Jiangsu, 225400, China (People's Republic of) Site Map … herbarium number meaning